Guardant Health (GH) Short Interest Ratio & Short Volume $45.16 +1.45 (+3.32%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Guardant Health Short Interest DataGuardant Health (GH) has a short interest of 8.28 million shares, representing 7.09% of the float (the number of shares available for trading by the public). This marks a -0.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 2.14 million shares to cover all short positions.Current Short Interest8,280,000 sharesPrevious Short Interest8,350,000 sharesChange Vs. Previous Month-0.84%Dollar Volume Sold Short$352.73 millionShort Interest Ratio3.5 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares123,421,000 sharesShort Percent of Float7.09%Today's Trading Volume1,680,155 sharesAverage Trading Volume2,141,074 sharesToday's Volume Vs. Average78% Short Selling Guardant Health? Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGH Short Interest Over TimeGH Days to Cover Over TimeGH Percentage of Float Shorted Over Time Remove Ads Guardant Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20258,280,000 shares $352.73 million -0.8%7.1%3.5 $42.60 3/15/20258,350,000 shares $358.13 million +5.7%7.2%3.6 $42.89 2/28/20257,900,000 shares $336.15 million +0.8%6.8%3.5 $42.55 2/15/20257,840,000 shares $377.26 million +35.9%6.7%3.7 $48.12 1/31/20255,770,000 shares $271.07 million -21.6%N/A2.7 $46.98 1/15/20257,360,000 shares $276 million -5.5%N/A3.6 $37.50 12/31/20247,790,000 shares $237.98 million -5.6%N/A4.3 $30.55 12/15/20248,250,000 shares $286.77 million -10.0%N/A4.7 $34.76 11/30/20249,170,000 shares $326.54 million -2.3%N/A4.7 $35.61 11/15/20249,390,000 shares $273.34 million -8.5%N/A4.4 $29.11 Get the Latest News and Ratings for GH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. 10/31/202410,260,000 shares $224.49 million -25.0%N/A4.9 $21.88 10/15/202413,680,000 shares $294.94 million -0.1%N/A6.1 $21.56 9/30/202413,690,000 shares $314.05 million +20.6%N/A6.1 $22.94 9/15/202411,350,000 shares $304.07 million +2.1%N/A5.1 $26.79 8/31/202411,120,000 shares $284.45 million +18.4%N/A5.4 $25.58 8/15/20249,390,000 shares $267.99 million +34.3%N/A4.4 $28.54 7/31/20246,990,000 shares $245.56 million +2.2%N/A3 $35.13 7/15/20246,840,000 shares $215.73 million -13.0%N/A3.4 $31.54 6/30/20247,860,000 shares $227.00 million +3.0%N/A3.8 $28.88 6/15/20247,630,000 shares $230.50 million -8.1%N/A3.3 $30.21 5/31/20248,300,000 shares $224.93 million -22.9%N/A3.5 $27.10 5/15/202410,760,000 shares $277.07 million +5.9%N/A4.7 $25.75 4/30/202410,160,000 shares $182.88 million +6.3%N/A5.3 $18.00 4/15/20249,560,000 shares $163.09 million +25.1%N/A4.8 $17.06 3/31/20247,640,000 shares $157.61 million -1.6%N/A4 $20.63 3/15/20247,760,000 shares $137.66 million +10.1%N/A4.8 $17.74 2/29/20247,050,000 shares $133.95 million +24.1%N/A4.3 $19.00 2/15/20245,680,000 shares $125.70 million +2.5%N/A3.6 $22.13 1/31/20245,540,000 shares $121.49 million +4.1%N/A3.5 $21.93 1/15/20245,320,000 shares $128.74 million +1.7%N/A3.2 $24.20 12/31/20235,230,000 shares $141.47 million -4.7%N/A3.3 $27.05 12/15/20235,490,000 shares $154.76 million -4.4%N/A3.3 $28.19 11/30/20235,740,000 shares $144.48 million -9.5%N/A3.4 $25.17 11/15/20236,340,000 shares $144.68 million -9.4%N/A3.5 $22.82 10/31/20237,000,000 shares $181.16 million -5.0%N/A4.2 $25.88 10/15/20237,370,000 shares $199.21 million +5.1%N/A4.6 $27.03 9/30/20237,010,000 shares $207.78 million +1.5%N/A4.5 $29.64 9/15/20236,910,000 shares $204.05 million -1.4%N/A4.5 $29.53 8/31/20237,010,000 shares $273.95 million +2.5%N/A4 $39.08 8/15/20236,840,000 shares $242.07 million -8.2%N/A3.4 $35.39New “Trump” currency proposed in DC (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 7/31/20237,450,000 shares $290.70 million -9.3%N/A3.4 $39.02 7/15/20238,210,000 shares $314.61 million -4.8%N/A3.8 $38.32 6/30/20238,620,000 shares $308.60 million +13.1%N/A4 $35.80 6/15/20237,620,000 shares $288.49 million +10.0%N/A3.5 $37.86 5/31/20236,930,000 shares $203.19 million -2.4%N/A3.4 $29.32 5/15/20237,100,000 shares $198.02 million +11.1%7.3%3.5 $27.89 4/30/20236,390,000 shares $144.16 million -8.6%6.5%3.3 $22.56 4/15/20236,990,000 shares $171.26 million +3.4%7.2%3.7 $24.50 3/31/20236,760,000 shares $158.45 million +7.1%6.9%3.4 $23.44 3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78 2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89 2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97 1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43 1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43 12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20 12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26 11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34 11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25 10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50 10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76 9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83 9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89 8/31/20224,610,000 shares $230.78 million +3.1%4.8%4.5 $50.06 8/15/20224,470,000 shares $246.03 million +5.9%4.6%4 $55.04 7/31/20224,220,000 shares $211.72 million +7.9%4.4%2.9 $50.17 7/15/20223,910,000 shares $190.46 million -2.3%4.1%2.6 $48.71 6/30/20224,000,000 shares $161.36 million -7.2%4.2%2.8 $40.34 6/15/20224,310,000 shares $165.59 million +7.5%4.5%3 $38.42 5/31/20224,010,000 shares $164.33 million +16.2%4.2%2.9 $40.98 5/15/20223,450,000 shares $123.89 million -11.8%3.6%2.5 $35.91 4/30/20223,910,000 shares $241.25 million +3.2%4.1%3.5 $61.70 4/15/20223,790,000 shares $272.84 million +0.8%4.0%3.6 $71.99 3/31/20223,760,000 shares $249.06 million -1.1%N/A0 $66.24 3/15/20223,800,000 shares $185.29 million -1.8%4.0%3.3 $48.76 2/28/20223,870,000 shares $256.46 million +13.2%4.1%3.3 $66.27 2/15/20223,420,000 shares $247.54 million -15.6%3.6%2.8 $72.38 1/31/20224,050,000 shares $281.68 million -4.5%4.3%3.3 $69.55 1/15/20224,240,000 shares $328.94 million +0.7%N/A3.6 $77.58 12/31/20214,210,000 shares $421.08 million -12.3%4.4%4 $100.02 12/15/20214,800,000 shares $463.39 million +11.4%5.1%4.3 $96.54 11/30/20214,310,000 shares $453.07 million +8.8%4.5%4.2 $105.12 11/15/20213,960,000 shares $410.45 million +5.9%4.2%4 $103.65 10/29/20213,740,000 shares $436.79 million -13.0%3.9%4.1 $116.79 10/15/20214,300,000 shares $436.88 million -7.1%4.5%4.7 $101.60 9/30/20214,630,000 shares $578.80 million +7.2%4.9%5.2 $125.01 9/15/20214,320,000 shares $548.64 million +3.4%4.6%5.5 $127.00 8/31/20214,180,000 shares $531.99 million +9.7%4.4%4.8 $127.27 8/13/20213,810,000 shares $385.88 million +16.2%4.0%4.3 $101.28 7/30/20213,280,000 shares $360.14 million -4.4%3.4%3.4 $109.80 7/15/20213,430,000 shares $389.72 million -12.7%3.6%3.6 $113.62New “Trump” currency proposed in DC (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 6/30/20213,930,000 shares $488.07 million +3.7%4.1%4 $124.19 6/15/20213,790,000 shares $446.05 million -4.8%4.2%3.9 $117.69 5/28/20213,980,000 shares $494.00 million -5.2%4.4%4.3 $124.12 5/14/20214,200,000 shares $461.03 million +1.0%4.7%4.2 $109.77 4/30/20214,160,000 shares $668.51 million -16.5%4.6%4.2 $160.70 4/15/20214,980,000 shares $772.05 million +0.6%N/A0 $155.03 3/31/20214,950,000 shares $726.61 million -0.6%5.6%4.7 $146.79 3/15/20214,980,000 shares $711.94 million +29.7%5.6%4.6 $142.96 2/26/20213,840,000 shares $573.89 million +3.5%4.3%3.4 $149.45 2/12/20213,710,000 shares $624.43 million +11.4%4.2%3.7 $168.31 1/29/20213,330,000 shares $521.74 million -17.0%3.9%3.1 $156.68 1/15/20214,010,000 shares $630.65 million +7.5%4.7%3.9 $157.27 12/31/20203,730,000 shares $470.50 million +13.0%4.4%3.6 $126.14 12/15/20203,300,000 shares $402.53 million +4.4%3.8%3.3 $121.98 11/30/20203,160,000 shares $374.97 million +66.3%3.7%3.1 $118.66 11/15/20201,900,000 shares $220.70 million -8.7%2.2%1.9 $116.16 10/30/20202,080,000 shares $228.13 million -2.8%2.4%2.3 $109.68 10/15/20202,140,000 shares $227.42 million -8.9%2.5%2.3 $106.27 9/30/20202,350,000 shares $262.68 million +6.3%3.0%2.6 $111.78 9/15/20202,210,000 shares $227.85 million -12.3%2.8%2.6 $103.10 8/31/20202,520,000 shares $240.66 million -4.6%3.3%3.1 $95.50 8/14/20202,640,000 shares $225.61 million -1.1%3.5%2.6 $85.46 7/31/20202,670,000 shares $227.43 million -5.3%3.5%2.6 $85.18 7/15/20202,820,000 shares $234.68 million -14.6%3.9%2.7 $83.22 6/30/20203,300,000 shares $267.73 million +39.2%4.7%3.1 $81.13 6/15/20202,370,000 shares $192.11 million +4.0%3.4%2.3 $81.06 5/29/20202,280,000 shares $206.09 million -1.7%3.6%2 $90.39 5/15/20202,320,000 shares $226.20 million -23.2%3.8%1.9 $97.50 4/30/20203,020,000 shares $232.42 million -12.7%3.7%2.4 $76.96 4/15/20203,460,000 shares $233.48 million +3.9%6.4%2.9 $67.48 GH Short Interest - Frequently Asked Questions What is Guardant Health's current short interest? Short interest is the volume of Guardant Health shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 8,350,000 shares of GH short. 7.15% of Guardant Health's shares are currently sold short. Learn More on Guardant Health's current short interest. What is a good short interest ratio for Guardant Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 4.0. Learn More on Guardant Health's short interest ratio. Which institutional investors are shorting Guardant Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: GTS Securities LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Nomura Holdings Inc., Millennium Management LLC, Group One Trading LLC, D. E. Shaw & Co. Inc., Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Boothbay Fund Management LLC, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Wells Fargo & Company MN, Pura Vida Investments LLC, Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Guardant Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.15% of Guardant Health's floating shares are currently sold short. Is Guardant Health's short interest increasing or decreasing? Guardant Health saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 8,350,000 shares, an increase of 5.7% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guardant Health's short interest compare to its competitors? 7.15% of Guardant Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Guardant Health: Natera, Inc. (3.16%), Fresenius Medical Care AG (0.13%), Hims & Hers Health, Inc. (30.08%), Option Care Health, Inc. (2.50%), RadNet, Inc. (8.31%), BrightSpring Health Services, Inc. (13.80%), Sotera Health (6.38%), Surgery Partners, Inc. (13.48%), Privia Health Group, Inc. (4.15%), LifeStance Health Group, Inc. (7.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Guardant Health stock? Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading up $2.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardant Health? A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further. How often is Guardant Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies NTRA Short Interest Data FMS Short Interest Data HIMS Short Interest Data OPCH Short Interest Data RDNT Short Interest Data BTSG Short Interest Data SHC Short Interest Data SGRY Short Interest Data PRVA Short Interest Data LFST Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GH) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredWARNING to All American InvestorsEveryone is focused on President Trump's trade war with China. But the real military showdown between China...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
